An intracellular <i>in situ</i> assembly of ultrasmall nanoparticles as drug depots for enhanced chemotherapy-Reference-Cited by-同舟云学术

An intracellular in situ assembly of ultrasmall nanoparticles as drug depots for enhanced chemotherapy

Published:2023 Issue:47 Volume:47 Page:21960-21968
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Feng Liandong¹,Chen Zhiyou¹,Dong Wei²^ORCID,Xie Aming³^ORCID,Zang Xiaowei⁴^ORCID,Li Juan¹^ORCID

Affiliation:

1. Department of Phase I Clinical Trials Unit, Nanjing DrumTower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing 210023, P. R. China

2. School of Chemistry and Chemical Engineering, Nanjing University of Science & Technology, Nanjing, 210094, P. R. China

3. School of Mechanical Engineering, Nanjing University of Science & Technology, Nanjing 210094, P. R. China

4. College of Safety Science and Engineering, Nanjing Tech University, Nanjing 211816, P. R. China

Abstract

An intracellular in situ assembly of nanoparticles with an initial ultrasmall size undergo transformation to micro-sized particles as drug depots inside tumour cells, which can highly improve the chemotherapy efficacy against B-cell lymphoma.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NJ/D3NJ04530G

Reference64 articles.

1. A Step-by-Step Multiple Stimuli-Responsive Nanoplatform for Enhancing Combined Chemo-Photodynamic Therapy

2. Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

3. Rethinking cancer nanotheranostics

4. Hierarchically Targeted and Penetrated Delivery of Drugs to Tumors by Size-Changeable Graphene Quantum Dot Nanoaircrafts for Photolytic Therapy

5. Analysis of nanoparticle delivery to tumours